MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration

E. Vasenina, O. Levin (Moscow, Russian Federation)

Meeting: MDS Virtual Congress 2020

Abstract Number: 790

Keywords: Aphasia, Cognitive dysfunction, Parkinsonism

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To classify and identify the features of speech disorders in Parkinson’s disease and other neurodegenerative diseases.

Background: No unified approach to classification and diagnostics of various speech disorder forms in neurodegenerative diseases (NDDs) including Parkinson’s disease (PD) has been developed to date.

Method: 1016 patients with NDDs were included in the study. All patients were screened for cortical speech disorders (pure dysarthria was not considered). Patients demonstrating speech and language disorders (42,1%) were examined using the speech disorder assessment test battery we have developed. Parkinsonism severity was assessed (where applicable) using part 3 of UPDRS, cognitive impairment was assessed using ACE-R, anxiety and depression using HADS, apathy-with AES.

Results: By means of cluster analysis and multifactorial analysis we identified 9 subtypes of speech disorders in NDDs as dysphasia. Contingency analysis allowed to match dysphasia with forms of NDDs and chi-squared index was used as specificity index [table 1]. All kinds of dysphasia were separated as core and additional for all forms of NDDs [figure 1]. In PD group (78 patients with prominent speech disorders) none of the dysphasia forms were associated with parkinsonism severity and general severity of cognitive impairment, which allowed to consider dysphasia as a separate clinical syndrome. Dysprosodic dysphasia differentiated by severity of axial symptoms (F value=3.279, p<0,05), adynamic dysphasia was associated with more pronounced apathy (F value =4,2, p<0,01), deconstructive dysphasia – with impairment of visual-spatial functioning (F value 29,93, p<0,0001), while logopenic dysphasia was associated with more severe attention deficiency.

Conclusion: Speech disorders in NDDs are heterogeneous and can be regarded as manifestations of dysphasia. Identification of various subtypes of dysphasia will allow for optimizing the treatment and prognosis of NDD and particularly PD patients.

Table 1

figure 1

To cite this abstract in AMA style:

E. Vasenina, O. Levin. Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/dysphasia-as-a-novel-approach-for-classification-of-speech-disorders-in-parkinsons-disease-and-other-forms-of-neurodegeneration/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/dysphasia-as-a-novel-approach-for-classification-of-speech-disorders-in-parkinsons-disease-and-other-forms-of-neurodegeneration/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley